Matthew Kaplan SEC EDGAR Filings (CIK 0001895952)

SEC EDGAR filings, ownership reports, and insider transactions for Matthew Kaplan.

Business address
C/O Nuvectis Pharma, Inc., 1 Bridge Plaza, Suite 275, Fort Lee, NJ, 07024
Top holdings (ownership)
NVCT
Get insider transactions for this reporting owner
Matthew Kaplan has filed 7 SEC EDGAR filings since 08 Feb 2022

Latest Filings

Recent SEC filings for Matthew Kaplan including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 06 Nov 2025 05 Nov 2025 001-41264
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 12 Jun 2025 12 Jun 2025 001-41264
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 13 Jun 2024 13 Jun 2024 001-41264
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 20 Jun 2023 16 Jun 2023 001-41264
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 16 May 2022 12 May 2022 001-41264
4 Open 4 document View SEC filing for 4 OWNERSHIP DOCUMENT 05 Apr 2022 01 Apr 2022 001-41264
3 Open 3 document View SEC filing for 3 OWNERSHIP DOCUMENT 08 Feb 2022 08 Feb 2022 001-41264

About this filer

Matthew Kaplan files with the SEC under CIK 0001895952. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages